Glaser Weil Represents TriMed in Sale of Majority Interest to Henry Schein

Glaser Weil represented TriMed Inc., a global developer of market-leading orthopedic implants, in the sale of a majority interest to Henry Schein, Inc. (NASDAQ: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners.

The deal was announced on December 20, 2023, and completed on April 4, 2024.

The Glaser Weil deal team was led by George Wall, partner and chair of the mergers and acquisitions practice, and included partners Matthew Jann and Jeffrey Soza and associates Gabriel Kiss and Lara Petersen.

For more information, read the press release.

Related Attorneys

  • George J. Wall
    Partner and Chair of the Mergers and Acquisitions Practice
  • Matthew J. Jann
    Partner and Co-chair of the Corporate Department
  • Jeffrey C. Soza
  • Gabriel E. Kiss
  • Lara A. Petersen
Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.